See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The world was transformed by the emergence of SARS-CoV-2, the ...

Pew Research Center conducted this study to understand Americans’ views of the coronavirus and COVID-19 vaccines. For this analysis, we surveyed 10,133 U.S. adults from Feb. 7 to 11, 2024. Everyone ...

COVID-19 viral activity was high in the United States during the first week of September, according to fresh data from the Centers for Disease Control and Prevention. Some regions of the United States ...

Novel Coronavirus (COVID-19) The COVID-19 pandemic caused by the novel coronavirus (SARS-CoV-2) continues to reshape the globe. Stay current with the latest updates essential for healthcare ...

A recent study published in Nature Communications explored the association of COVID-19 with long-term allergic conditions. Study: Incident allergic diseases in post-COVID-19 condition: multinational ...

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

Clockwise from top left: A second-grader does remote schoolwork at the Reading, Pennsylvania, Boys and Girls Club in January 2021. Protesting against COVID-19 vaccine mandates in Buffalo, New York, in ...

Americans can no longer order free at-home COVID-19 tests from the government through COVIDtests.gov. The suspension of the program, which has distributed over 1.8 billion COVID tests across the ...

Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk for ...

A variant of COVID-19 called BA.3.2, which has circulated under the radar since late 2024, is now spreading quickly across the United States. There’s no sign so far that BA.3.2, nicknamed Cicada, is ...